Literature DB >> 24794154

The role of 5-HTTLPR polymorphism in alcohol craving experience.

Samuel Pombo1, Joana Ferreira2, José Maria Neves Cardoso3, Fátima Ismail3, Pilar Levy2, Manuel Bicho2.   

Abstract

The way in which genetic risk mediates the development of craving in alcohol dependence is still relatively unknown. The authors sought to clarify the extent to which alcohol craving could be predicted by a relevant polymorphism in the promoter region of the gene encoding the 5-HT transporter (5-HTTLPR). A sample of 101 alcohol-dependent patients admitted for alcohol treatment was recruited for the study. At admission, blood samples were taken for DNA extraction and alcohol craving information was collected with a composite measure. The 5-HTT polymorphism was genotyped. Alcohol dependent patients who were homozygous for the long allele (LL) self-reported higher scores of craving when compared to patients that were homozygous for the short allele (SS). However, the results were not statistically significant. Also, no significant associations were observed between the 5-HTTLPR genotype and other drinking variables. No 5-HTTLPR genotype effects were observed on alcohol craving experience in a sample of alcohol-dependent outpatients.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol craving; Alcohol dependence; Gene of the serotonin transporter

Mesh:

Substances:

Year:  2014        PMID: 24794154     DOI: 10.1016/j.psychres.2014.04.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South America.

Authors:  João Mauricio Castaldelli-Maia; Yuan-Pang Wang; Guilherme Borges; Camila M Silveira; Erica R Siu; Maria C Viana; Arthur G Andrade; Silvia S Martins; Laura H Andrade
Journal:  Drug Alcohol Depend       Date:  2015-05-09       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.